Kidney disease in children and adolescents with perinatal HIV-1 infection

Rajendra Bhimma1, Murli Udharam Purswani, Udai Kala

  • 1Department of Paediatrics and Child Health, School of Clinical Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. bhimma@ukzn.ac.za

Insights

Highly active anti-retroviral therapy (HAART) has improved outcomes for children with HIV-1 kidney disease, particularly HIV-associated nephropathy (HIVAN). However, other kidney issues and drug toxicities require ongoing attention and research.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • Children with perinatal HIV-1 infection face diverse kidney issues, including acute kidney injury, UTIs, electrolyte imbalances, nephrotoxicity, and glomerular diseases.
  • HIV-associated nephropathy (HIVAN) was a common cause of chronic kidney disease (CKD) in these children, often leading to end-stage kidney disease.

Purpose of the Study:

  • To review the pathogenesis, genetics, clinical presentation, and management of kidney diseases in children and adolescents with perinatal HIV-1 infection.
  • To highlight the impact of highly active anti-retroviral therapy (HAART) on HIV-associated kidney disease outcomes.
  • To discuss current and future strategies for screening, prevention, and treatment of kidney disease in this population.

Main Methods:

  • Literature review focusing on pathogenesis, genetics, clinical presentation, and management.
  • Analysis of the impact of HAART on HIV-associated nephropathy (HIVAN) and other kidney diseases.
  • Evaluation of renal replacement therapies including hemodialysis, peritoneal dialysis, and kidney transplantation.

Main Results:

  • HAART has significantly reduced HIVAN incidence and improved prognosis, allowing long-term survival.
  • The impact of HAART on other kidney diseases and drug-induced nephrotoxicity is less pronounced.
  • Both hemodialysis and peritoneal dialysis are effective renal replacement therapies, with peritoneal dialysis favored in resource-limited settings.

Conclusions:

  • Understanding the molecular pathogenesis and genetics of HIV-related kidney disease is crucial for improved care.
  • Kidney transplantation is now a viable and effective renal replacement therapy for selected HIV-infected patients.
  • Routine kidney disease screening is recommended for HIV-infected children and adolescents where resources permit.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...